This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
St. Jude Medical, Inc.
St. Jude Medical, Inc., a prominent player in the medical device industry, is headquartered in the United States. Founded in 1976, the company has established itself as a leader in cardiovascular, neuromodulation, and electrophysiology solutions. With a strong presence in North America, Europe, and Asia, St. Jude Medical focuses on innovative technologies that enhance patient care and improve clinical outcomes. The company’s core products include advanced cardiac rhythm management devices, heart valves, and neurostimulation systems, all designed to address complex medical conditions. St. Jude Medical is recognised for its commitment to quality and innovation, having achieved significant milestones such as pioneering minimally invasive procedures. As part of Abbott, St. Jude Medical continues to solidify its market position, contributing to advancements in healthcare and improving the lives of patients worldwide.
DitchCarbon Score
How does St. Jude Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
St. Jude Medical, Inc.'s score of 54 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
St. Jude Medical, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is part of a corporate family that includes Abbott Laboratories, from which it inherits emissions data and climate commitments. As a merged entity, St. Jude Medical follows the sustainability initiatives and targets set by Abbott Laboratories. However, specific reduction targets or achievements for St. Jude Medical itself have not been disclosed. The company is expected to align with the climate strategies and reporting frameworks established by Abbott, which include commitments to the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). While no absolute emissions figures are provided, St. Jude Medical's climate commitments are likely influenced by the broader goals of its parent company, focusing on reducing Scope 1, 2, and 3 emissions in line with industry standards. The absence of specific data highlights the need for ongoing transparency and accountability in corporate climate strategies.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
St. Jude Medical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
